NO20042604L - Behandling av mikroorganismeinfeksjoner - Google Patents
Behandling av mikroorganismeinfeksjonerInfo
- Publication number
- NO20042604L NO20042604L NO20042604A NO20042604A NO20042604L NO 20042604 L NO20042604 L NO 20042604L NO 20042604 A NO20042604 A NO 20042604A NO 20042604 A NO20042604 A NO 20042604A NO 20042604 L NO20042604 L NO 20042604L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- microorganism infections
- antibody
- infections
- microorganism
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0127983.5A GB0127983D0 (en) | 2001-11-22 | 2001-11-22 | Treatment of micro-organism infection |
| PCT/GB2002/005135 WO2003046007A2 (en) | 2001-11-22 | 2002-11-13 | Treatment of micro-organism infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20042604L true NO20042604L (no) | 2004-06-21 |
Family
ID=9926237
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20042604A NO20042604L (no) | 2001-11-22 | 2004-06-21 | Behandling av mikroorganismeinfeksjoner |
| NO20081575A NO20081575L (no) | 2001-11-22 | 2008-03-31 | Behandling av mikroorganismeinfeksjoner |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20081575A NO20081575L (no) | 2001-11-22 | 2008-03-31 | Behandling av mikroorganismeinfeksjoner |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US20050118162A1 (ru) |
| EP (2) | EP1964851A1 (ru) |
| JP (1) | JP2005511645A (ru) |
| CN (2) | CN100371348C (ru) |
| AT (1) | ATE427320T1 (ru) |
| AU (2) | AU2002339159B2 (ru) |
| BR (1) | BR0214363A (ru) |
| CA (1) | CA2465072A1 (ru) |
| DE (1) | DE60231825D1 (ru) |
| DK (1) | DK1446425T3 (ru) |
| ES (1) | ES2322756T3 (ru) |
| GB (1) | GB0127983D0 (ru) |
| NO (2) | NO20042604L (ru) |
| NZ (1) | NZ533623A (ru) |
| PL (1) | PL369536A1 (ru) |
| PT (1) | PT1446425E (ru) |
| RU (1) | RU2303460C2 (ru) |
| WO (1) | WO2003046007A2 (ru) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0127983D0 (en) * | 2001-11-22 | 2002-01-16 | Neutec Pharma Plc | Treatment of micro-organism infection |
| US20070202186A1 (en) | 2006-02-22 | 2007-08-30 | Iscience Interventional Corporation | Apparatus and formulations for suprachoroidal drug delivery |
| JP5248032B2 (ja) * | 2007-04-23 | 2013-07-31 | 株式会社Ａｄｅｋａ | ケイ素含有化合物、硬化性組成物及び硬化物 |
| JP5248033B2 (ja) * | 2007-04-23 | 2013-07-31 | 株式会社Ａｄｅｋａ | ケイ素含有化合物、硬化性組成物及び硬化物 |
| WO2008132174A1 (en) * | 2007-04-27 | 2008-11-06 | Novartis Ag | An immunoglobulin composition |
| US20100113355A1 (en) | 2007-04-27 | 2010-05-06 | Naresh Chennamsetty | Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
| BRPI1010911A2 (pt) * | 2009-05-18 | 2019-09-24 | Julius Maximilians Univ Wuerzburg De/De | "anticorpos ou fragmentos destes direcionados contra um epitopo de staphylococcus aureus" |
| AU2010271582B2 (en) * | 2009-07-15 | 2016-07-28 | Aimm Therapeutics B.V. | Gram-positive bacteria specific binding compounds |
| WO2011084882A2 (en) | 2010-01-05 | 2011-07-14 | Contrafect Corporation | Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria |
| BR112013009205A2 (pt) | 2010-10-15 | 2016-07-26 | Iscience Interventional Corp | dispositivo para colocação na esclera de um olho, método para acessar o espaço supracoroidal de um olho, para acessar o espaço subretinal de um olho e para colocar um orifício dentro de um trato escleral em um olho. |
| AU2011317021B2 (en) * | 2010-10-20 | 2015-07-09 | Medimmune, Llc | Methods for processing inclusion bodies |
| BR112015027762A2 (pt) | 2013-05-03 | 2017-08-29 | Clearside Biomedical Inc | Aparelho e métodos para injeção ocular |
| RU2572341C2 (ru) * | 2013-09-20 | 2016-01-10 | Федеральное государственное бюджетное учреждение Научно-исследовательский институт по изысканию новых антибиотиков имени Г.Ф. Гаузе Российской академии медицинских наук (ФГБУ "НИИНА" РАМН) | АНТИБИОТИК ИНА 5812, ШТАММ-ПРОДУЦЕНТ Streptomyces roseoflavus ИНА-Ас-5812 И СПОСОБ ПОЛУЧЕНИЯ АНТИБИОТИКА |
| EP3452165A1 (en) | 2016-05-02 | 2019-03-13 | Clearside Biomedical, Inc. | Systems and methods for ocular drug delivery |
| CA3072847A1 (en) | 2016-08-12 | 2018-02-15 | Clearside Biomedical, Inc. | Devices and methods for adjusting the insertion depth of a needle for medicament delivery |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| NZ291659A (en) * | 1994-09-06 | 2001-04-27 | Galagen Inc | Use in the manufacture of a medicament of an antibody having specific activity against Clostridium difficile, and pharmaceutical compositions comprising Anti-Clostridium difficile bovine immunoglobulin concentrate; for treating diseases associated with Clostridium difficile |
| GB9614274D0 (en) * | 1996-07-06 | 1996-09-04 | Univ Manchester | Treatment and diagnosis of infections of gram positive cocci |
| GB9806762D0 (en) * | 1998-03-31 | 1998-05-27 | Neutec Pharma Plc | Treatment and diagnosis of staphylococcal infections |
| GB0127983D0 (en) * | 2001-11-22 | 2002-01-16 | Neutec Pharma Plc | Treatment of micro-organism infection |
-
2001
- 2001-11-22 GB GBGB0127983.5A patent/GB0127983D0/en not_active Ceased
-
2002
- 2002-11-13 AU AU2002339159A patent/AU2002339159B2/en not_active Ceased
- 2002-11-13 JP JP2003547456A patent/JP2005511645A/ja active Pending
- 2002-11-13 NZ NZ533623A patent/NZ533623A/en not_active IP Right Cessation
- 2002-11-13 EP EP08005286A patent/EP1964851A1/en not_active Withdrawn
- 2002-11-13 CN CNB028231783A patent/CN100371348C/zh not_active Expired - Fee Related
- 2002-11-13 CN CNA2008100036489A patent/CN101254304A/zh active Pending
- 2002-11-13 PT PT02777534T patent/PT1446425E/pt unknown
- 2002-11-13 CA CA002465072A patent/CA2465072A1/en not_active Abandoned
- 2002-11-13 DE DE60231825T patent/DE60231825D1/de not_active Expired - Lifetime
- 2002-11-13 RU RU2004118716/13A patent/RU2303460C2/ru not_active IP Right Cessation
- 2002-11-13 US US10/496,507 patent/US20050118162A1/en not_active Abandoned
- 2002-11-13 AT AT02777534T patent/ATE427320T1/de not_active IP Right Cessation
- 2002-11-13 ES ES02777534T patent/ES2322756T3/es not_active Expired - Lifetime
- 2002-11-13 DK DK02777534T patent/DK1446425T3/da active
- 2002-11-13 WO PCT/GB2002/005135 patent/WO2003046007A2/en active IP Right Grant
- 2002-11-13 EP EP02777534A patent/EP1446425B1/en not_active Expired - Lifetime
- 2002-11-13 PL PL02369536A patent/PL369536A1/xx not_active IP Right Cessation
- 2002-11-13 BR BR0214363-1A patent/BR0214363A/pt not_active IP Right Cessation
-
2004
- 2004-06-21 NO NO20042604A patent/NO20042604L/no not_active Application Discontinuation
-
2007
- 2007-02-23 US US11/709,952 patent/US20070202116A1/en not_active Abandoned
- 2007-10-31 US US11/931,099 patent/US20080171054A1/en not_active Abandoned
-
2008
- 2008-03-31 NO NO20081575A patent/NO20081575L/no not_active Application Discontinuation
- 2008-09-04 AU AU2008212001A patent/AU2008212001A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN1589280A (zh) | 2005-03-02 |
| JP2005511645A (ja) | 2005-04-28 |
| US20050118162A1 (en) | 2005-06-02 |
| AU2002339159B2 (en) | 2008-06-05 |
| BR0214363A (pt) | 2004-10-26 |
| EP1446425B1 (en) | 2009-04-01 |
| DE60231825D1 (de) | 2009-05-14 |
| NO20081575L (no) | 2004-06-21 |
| AU2002339159A1 (en) | 2003-06-10 |
| EP1964851A1 (en) | 2008-09-03 |
| RU2004118716A (ru) | 2005-03-27 |
| AU2008212001A1 (en) | 2008-09-25 |
| CN101254304A (zh) | 2008-09-03 |
| NZ533623A (en) | 2005-12-23 |
| GB0127983D0 (en) | 2002-01-16 |
| US20070202116A1 (en) | 2007-08-30 |
| CA2465072A1 (en) | 2003-06-05 |
| WO2003046007A3 (en) | 2004-03-11 |
| US20080171054A1 (en) | 2008-07-17 |
| DK1446425T3 (da) | 2009-07-20 |
| CN100371348C (zh) | 2008-02-27 |
| PT1446425E (pt) | 2009-07-01 |
| EP1446425A2 (en) | 2004-08-18 |
| RU2303460C2 (ru) | 2007-07-27 |
| ATE427320T1 (de) | 2009-04-15 |
| PL369536A1 (en) | 2005-05-02 |
| WO2003046007A2 (en) | 2003-06-05 |
| ES2322756T3 (es) | 2009-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20081575L (no) | Behandling av mikroorganismeinfeksjoner | |
| ATE383375T1 (de) | Wti-modifiziertes peptid | |
| CY1112833T1 (el) | Καινοφανης προσδετης της κυτοκινης ζcυτοr17 | |
| FR2792202B1 (fr) | Extrait peptidique de lupin et composition pharmaceutique ou cosmetique ou nutraceutique comprenant un tel extrait | |
| BR0209434A (pt) | Peptìdeos antimicrobianos e composições | |
| ES2137310T3 (es) | Vacuna contra una infeccion por streptococcus suis. | |
| DE60228136D1 (de) | Cytokin-proteinfamilie | |
| ATE362481T1 (de) | Lantibiotikum | |
| DE60332425D1 (de) | 5t4-antigen-peptidepitope der mhc klasse ii | |
| GB0203419D0 (en) | Peptide | |
| DK1368372T3 (da) | Peptid med affinitet til det virale gp120-protein samt anvendelse deraf | |
| WO1999057142A3 (en) | Vaccine for $i(pseudomonas aeruginosa) | |
| NZ591827A (en) | Biologically active peptides comprising PTTKTYFPHF and their uses in the manufacture of a medicament for modulating immune reaction in a radiotherapy-induced immuno-compromised subject | |
| RS49520B (sr) | Antimikrobno aktivne smeše | |
| ATE514716T1 (de) | Fragmente toxin-bezogener antikörper, mit antimikrobieller und antiviraler aktivität | |
| WO2002085934A3 (fr) | Peptides antibacteriens, les compositions les contenant et leurs utilisations | |
| HUP0300787A2 (hu) | Új interferon a sclerosis multiplex kezelésére | |
| EP1557466A4 (en) | TUMOR ANTIGEN PROTEIN AND USE THEREOF | |
| NZ508812A (en) | Peptides for the prevention or treatment of HIV | |
| WO2001058471A3 (en) | Novel amino acid and peptide inhibitors of staphylococcus virulence | |
| DE60022995D1 (de) | Impfstoff | |
| WO2003027274A3 (en) | Purified polypeptides from pseudomonas aeruginosa | |
| MY143402A (en) | Preparations used in the treatment and prophilaxis of mycobacterial infections | |
| CO4820441A1 (es) | Antigeno bm 95 de la garrapata boophilus microplus, aislamiento, secuencia, adn recombinantes, microorganismos transformados y preparacion vacunal | |
| WO2004041856A3 (en) | Crystal structures of bacterial inorganic pyrophosphatases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |